The asthma diagnosis jigsaw puzzle: an adaptable teaching concept to facilitate the diagnosis of asthma in adults and children presenting to primary care

Introduction: what is the need for improved diagnosis of asthma in primary care given the availability of national and international guidelines?

Asthma is one of the most common chronic diseases encountered in primary care. The reported prevalence of asthma varies across countries, ranging from 1%–18%1, although high rates of misdiagnosis are also well documented2,3,4. Evidence-based guidelines and consensus recommendations exist to support clinicians with asthma diagnosis5,6,7,8. For example, treatment pathways provided by the Global Initiative for Asthma (GINA), start from diagnosis based on symptoms and a demonstration of variable airflow obstruction (and/or reversibility) using peak flow and/or spirometry9. Where available, bronchodilator responsiveness (reversibility) testing is recommended for adults and children from 5 years, when they are symptomatic. However, in practice, this can be difficult as lung function is often normal when the patient is asymptomatic or has received treatment. There are currently no tests recommended for children <5 years, typically diagnosis is based on history, observation and context, often over a period of time. In this group, asthma should be suspected if there are recurring episodes of cough, breathlessness and/or wheeze occurring with or between viral infections, that respond to bronchodilators or a trial of inhaled corticosteroids, and where there is a patient or family history of atopy10.

Current guidelines and consensus statements are typically generated by respiratory specialists using data from research studies. Such guidelines are weighted towards specialist or secondary care settings and tend to be linear or algorithmic in approach. As such they do not capture or incorporate the expertise and flexibility used by expert practitioners in primary care in guideline implementation. Here, first contact presentations with multi-morbidity are increasingly common necessitating the use of multiple, sometimes overlapping, protocols, and information is often gathered in an iterative rather than linear manner11. Additionally, access to diagnostic investigations (such as routine availability of peak flow meters or spirometry) and continuity of care is either limited or absent in many countries.

Methods: how was the asthma diagnosis jigsaw puzzle teaching concept developed?

The concept of the jigsaw puzzle emerged from discussions between a small group of family physicians with an interest in respiratory care. To test and refine it as a diagnostic clinical practice and teaching concept, a multidisciplinary group of 20 primary care asthma experts from 14 countries was convened. The group included family physicians, a nurse, two pharmacists and adult and paediatric asthma specialists (Table 1). An in-person facilitated workshop was held over 2 days during the world conference of the International Primary Care Respiratory Group, followed by online consultations.

Table 1 Details of participants in consensus development process.
Full size table

A three-round modified nominal group technique was used during the workshops12, conducted in English. This used an adapted teaching method also known as the jigsaw teaching method (Fig. 1)13 to facilitate collaboration and consensus building. Drawing on international expertise enabled content to reflect asthma diagnosis in a variety of settings, envisaging adaptation of the teaching concept across different language and resource contexts.

Fig. 1
figure 1

The asthma diagnosis, jigsaw puzzle development process.

Full size image

Prior to the workshop, the faculty categorised the asthma diagnostic process into four domains: presenting symptoms, physical examination and investigations, predisposing factors and precipitating factors, informed by case formulation used in biopsychosocial approaches14. Participants were advised that the goal was to build an asthma jigsaw puzzle. For Assignment 1, participants were allocated to one of the domain groups based on role, country and area of expertise. Each domain group was invited by the facilitators to discuss and agree on the most important factors—jigsaw pieces—in their domain which were described using the ‘why/how/when/who’ framework to justify inclusion (Box 1).

During the workshop, the original terms “predisposing factors” and “precipitating factors” (i.e. what prompted the presentation) were revised following vigorous debate. The final categorisation of domains was clarified as follows: Presentation, history, symptoms and physical examination and objective tests, to ease understanding of the multi-national primary care audience.

In Assignment 2, participants were each asked to move to a different table so that all four domains were represented at each table. Participants advocated for their jigsaw pieces, duplicates were prioritised and by consensus placed in the most relevant domain.

For Assignment 3, participants came together as a whole group, presenting and agreeing the final puzzle pieces required to construct a complete jigsaw puzzle. This final stage was led by two facilitators, one ensuring that all groups had the opportunity to speak, the other ensuring clarity and accuracy of language for each item of content and related descriptors.

A video summary of these stages can be seen here.

Following the in-person workshops, expert participants were invited to form a writing group. This group met three times. There was consensus that the metaphor of a jigsaw puzzle would be a helpful educational and teaching concept. The group decided that key outputs from the workshop should be a desktop helper, a practical two-page guide for global primary care and at least one peer-reviewed publication that explained the process. A sub-group finalised the desktop helper and, after trial and error, chose a famous image to illustrate the jigsaw puzzle metaphor as shown in Fig. 2.

Fig. 2
figure 2

Using a jigsaw puzzle metaphor to facilitate the diagnosis of asthma in primary care.

Full size image

Discussion: how does the asthma diagnosis jigsaw puzzle teaching concept add value to the challenge of asthma diagnosis?

The Asthma Diagnosis Jigsaw Puzzle is a practical and adaptable teaching concept which aims to improve confidence and competence in the diagnosis of asthma for adults and children, irrespective of resource setting. There are different ways to complete a jigsaw puzzle. A primary care clinician starts by finding the four corners, which, in the jigsaw puzzle metaphor could represent either the cardinal symptoms of asthma, (wheeze, cough, breathlessness and tight chest) or the domains (presentation, symptoms and physical examination, history and objective tests). At least some of these would point the clinician towards a diagnosis of asthma. Additional jigsaw pieces are then required to build the picture, systematically collected from the (adult) patient or, in the case of children, from the caregiver, within categories of history, physical examination and objective tests. Where puzzle pieces do not fit, they can be considered as belonging to a different picture, prompting a reformulation of diagnostic hypotheses (Fig. 2). Over time, through gathering information the picture becomes clearer, but it is only fully complete when the central pieces (in our image, the nose and mouth) are added. These are the objective test results. Where such objective tests are not available, the final puzzle picture can often still be defined, though not as clearly as when tests are utilised. It is not intended as an exhaustive list of differential diagnoses or to provide an overview of all the complexities of making a diagnosis.

The jigsaw puzzle metaphor fits intuitive, problem-solving and pattern mapping approaches mastered by expert primary care clinicians. The process of combining pieces becomes easier over time and with experience, as patterns are recognised more reliably. Just like a jigsaw puzzle, the final picture of the diagnosis gradually takes shape, as patient and clinician identify new puzzle pieces. Adaptation of the teaching concept includes both translation of key puzzle pieces across language groups, with adjustment of content to reflect commonly encountered symptoms, history, and objective tests e.g. haemoptysis – as a non-fitting piece – in settings where TB is highly prevalent.

Communication approaches using the language of puzzle completion during clinical encounters opens the possibility for patients and families to participate in the diagnostic process. Patients and caregivers are invited to gain an understanding of the complex and changing nature of symptoms and of their disease. By responding to the idea of working together with their clinician to complete ‘the puzzle’ of diagnosis, this also enables uncertainty to be visualised within the diagnostic process rather than understood as a lack of competence on the part of their healthcare provider. In some countries ‘doctor shopping’15 is common for patients in primary care, and continuity of care is particularly challenging. The value of follow up can be emphasised using a puzzle metaphor, patients and caregivers can be reassured, guided and educated by the process of working together with the clinician to achieve the diagnosis over time.

Future plans: adaptation and roll-out of teaching resources

The launch of the asthma diagnostic jigsaw puzzle teaching concept has yielded positive responses internationally, at the WONCA World 2023 Conference, the European Respiratory Society 2023 Congress, the International Primary Care Respiratory Group’s World Conference 2024, European Academy of Allergy and Clinical Immunology (EAACI) 2024 Conference and WONCA Europe conference 2024.

A new clinical practice and teaching resource, the ‘Desktop Helper no.15: the jigsaw puzzle approach to building a diagnostic picture of asthma in primary care over time’ has been translated from English and received positive feedback when used for teaching health professionals in North Macedonia. It is available online in a variety of languages (Fig. 3) and includes details of puzzle pieces in each domain which do not fit, where an alternative diagnosis may be relevant.

Fig. 3
figure 3

The asthma diagnosis jigsaw puzzle desktop helper, examples in three languages (English, Spanish, Chinese).

Full size image

The development of additional resources to support teaching, learning and local adaptation of the asthma diagnosis jigsaw puzzle teaching concept is underway. These include locally developed case vignettes. The fidelity of the jigsaw puzzle metaphor as an adaptable teaching concept will be tested through evaluation of upcoming workshops in Uganda, Malaysia and India.

Conclusion

The variability of asthma symptoms over time and the absence of any single objective diagnostic test poses a problem for diagnosis of asthma internationally. Achieving the correct diagnosis is essential to ensure adults and children receive the right care including pharmacological treatment with inhaled medications and non-pharmacological interventions. The asthma diagnosis jigsaw puzzle teaching concept is a succinct, adaptable symptom-based approach relevant for first contact and follow-up clinical encounters in primary care. It has the potential to support more effective diagnosis of asthma and improved clinical outcomes, along with the delivery of patient-centred care. Teaching resources have been developed and are being disseminated internationally.

Related Articles

Energy metabolism in health and diseases

Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This review provides an extensive overview of advancements in energy metabolism research, elucidating critical pathways such as glycolysis, oxidative phosphorylation, fatty acid metabolism, and amino acid metabolism, along with their intricate regulatory mechanisms. The homeostatic balance of these processes is crucial; however, in pathological states such as neurodegenerative diseases, autoimmune disorders, and cancer, extensive metabolic reprogramming occurs, resulting in impaired glucose metabolism and mitochondrial dysfunction, which accelerate disease progression. Recent investigations into key regulatory pathways, including mechanistic target of rapamycin, sirtuins, and adenosine monophosphate-activated protein kinase, have considerably deepened our understanding of metabolic dysregulation and opened new avenues for therapeutic innovation. Emerging technologies, such as fluorescent probes, nano-biomaterials, and metabolomic analyses, promise substantial improvements in diagnostic precision. This review critically examines recent advancements and ongoing challenges in metabolism research, emphasizing its potential for precision diagnostics and personalized therapeutic interventions. Future studies should prioritize unraveling the regulatory mechanisms of energy metabolism and the dynamics of intercellular energy interactions. Integrating cutting-edge gene-editing technologies and multi-omics approaches, the development of multi-target pharmaceuticals in synergy with existing therapies such as immunotherapy and dietary interventions could enhance therapeutic efficacy. Personalized metabolic analysis is indispensable for crafting tailored treatment protocols, ultimately providing more accurate medical solutions for patients. This review aims to deepen the understanding and improve the application of energy metabolism to drive innovative diagnostic and therapeutic strategies.

Exploring the potential of LLM to enhance teaching plans through teaching simulation

The introduction of large language models (LLMs) may change future pedagogical practices. Current research mainly focuses on the use of LLMs to tutor students, while the exploration of LLMs’ potential to assist teachers is limited. Taking high school mathematics as an example, we propose a method that utilizes LLMs to enhance the quality of teaching plans through guiding the LLM to simulate teacher-student interactions, generate teaching reflections, and subsequently direct the LLM to refine the teaching plan by integrating these teaching process and reflections. Human evaluation results show that this method significantly elevates the quality of the original teaching plans generated directly by LLM. The improved teaching plans are comparable to high-quality ones crafted by human teachers across various assessment dimensions and knowledge modules. This approach provides a pre-class rehearsal simulation and ideas for teaching plan refinement, offering practical evidence for the widespread application of LLMs in teaching preparation.

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

Macrophages are immune cells belonging to the mononuclear phagocyte system. They play crucial roles in immune defense, surveillance, and homeostasis. This review systematically discusses the types of hematopoietic progenitors that give rise to macrophages, including primitive hematopoietic progenitors, erythro-myeloid progenitors, and hematopoietic stem cells. These progenitors have distinct genetic backgrounds and developmental processes. Accordingly, macrophages exhibit complex and diverse functions in the body, including phagocytosis and clearance of cellular debris, antigen presentation, and immune response, regulation of inflammation and cytokine production, tissue remodeling and repair, and multi-level regulatory signaling pathways/crosstalk involved in homeostasis and physiology. Besides, tumor-associated macrophages are a key component of the TME, exhibiting both anti-tumor and pro-tumor properties. Furthermore, the functional status of macrophages is closely linked to the development of various diseases, including cancer, autoimmune disorders, cardiovascular disease, neurodegenerative diseases, metabolic conditions, and trauma. Targeting macrophages has emerged as a promising therapeutic strategy in these contexts. Clinical trials of macrophage-based targeted drugs, macrophage-based immunotherapies, and nanoparticle-based therapy were comprehensively summarized. Potential challenges and future directions in targeting macrophages have also been discussed. Overall, our review highlights the significance of this versatile immune cell in human health and disease, which is expected to inform future research and clinical practice.

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines. The integration of novel drug design and synthesis techniques, display library technology, delivery systems, bioengineering advancements, and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs, effectively addressing the obstacles associated with their character, such as the rapid clearance and degradation, necessitating subcutaneous injection leading to increasing patient discomfort, and ultimately advancing translational research efforts. Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions, such as diabetes mellitus, weight loss, oncology, and rare diseases, and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines. This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics, delivery platforms, and vaccines. It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs, as well as the recent advancements in screening, design, and delivery technologies. The accelerated advancement in the development of novel peptide-based therapeutics, including peptide-drug complexes, new peptide-based vaccines, and innovative peptide-based diagnostic reagents, has the potential to promote the era of precise customization of disease therapeutic schedule.

Type 2 immunity in allergic diseases

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect against parasitic diseases and toxins, plays a role in the expulsion of parasites and larvae from inner tissues to the lumen and outside the body, maintains microbe-rich skin and mucosal epithelial barriers and counterbalances the type 1 immune response and its destructive effects. During the development of a type 2 immune response, an innate immune response initiates starting from epithelial cells and innate lymphoid cells (ILCs), including dendritic cells and macrophages, and translates to adaptive T and B-cell immunity, particularly IgE antibody production. Eosinophils, mast cells and basophils have effects on effector functions. Cytokines from ILC2s and CD4+ helper type 2 (Th2) cells, CD8 + T cells, and NK-T cells, along with myeloid cells, including IL-4, IL-5, IL-9, and IL-13, initiate and sustain allergic inflammation via T cell cells, eosinophils, and ILC2s; promote IgE class switching; and open the epithelial barrier. Epithelial cell activation, alarmin release and barrier dysfunction are key in the development of not only allergic diseases but also many other systemic diseases. Recent biologics targeting the pathways and effector functions of IL4/IL13, IL-5, and IgE have shown promising results for almost all ages, although some patients with severe allergic diseases do not respond to these therapies, highlighting the unmet need for a more detailed and personalized approach.

Responses

Your email address will not be published. Required fields are marked *